Prothena Past Performance

Past criteria checks 0/6

Prothena has been growing earnings at an average annual rate of 23.7%, while the Biotechs industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 56.5% per year.

Key information


Earnings growth rate


EPS growth rate

Biotechs Industry Growth44.3%
Revenue growth rate56.5%
Return on equity-21.0%
Net Margin-232.2%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Earnings and Revenue History

Quality Earnings: 0PT is currently unprofitable.

Growing Profit Margin: 0PT is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: 0PT is unprofitable, but has reduced losses over the past 5 years at a rate of 23.7% per year.

Accelerating Growth: Unable to compare 0PT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0PT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15.9%).

Return on Equity

High ROE: 0PT has a negative Return on Equity (-20.99%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies